Clinical trial
A Study for Patients With Attention-Deficit/Hyperactivity Disorder Treated With…
NCT00471354 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00471354 |
|---|---|
| Title | A Study for Patients With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine |
| Official title | Evaluation of Academic Performance in Asian Children Aged 8 to 11 Years With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine Hydrochloride |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Attention Deficit Hyperactivity Disorder |
| Intervention type | Drug |
| Interventions | Atomoxetine |
| Enrollment | 228 |
| Start date | Apr 1, 2007 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | May 9, 2007 |
| Last update posted | Jan 12, 2010 |
| Countries | China, South Korea, Taiwan |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: